Skip to main content

Table 3 Medical treatment of 123 patients with Hypertrophic Cardiomyopathy

From: Identification of high risk patients with hypertrophic cardiomyopathy in a northern Greek population

Medication 80 (65%)
b-blocker 59 (47.9%)
verapamil 4 (3.2%)
disopyramide 3 (2.4%)
amiodaron 10 (8.1%)
diltiazem 5 (4%)
warfarin 9 (7.3%)
CEI/ARBs 13 (10.5%)
Statins 13 (10.5%)
Diuretics 8 (6.5%)
Digoxin 2 (1.6%)
Aspirin/clopidogrel 16 (13%)
No Medication 43 (35%)